Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$335M |
| 2 |
Amazon
AMZN
|
+$287M |
| 3 |
Otis Worldwide
OTIS
|
+$260M |
| 4 |
Alibaba
BABA
|
+$245M |
| 5 |
FlexShares iBoxx 3-Year Target Duration TIPS Index Fund
TDTT
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$720M |
| 2 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$365M |
| 3 |
RTN
Raytheon Company
RTN
|
+$357M |
| 4 |
Schwab US Broad Market ETF
SCHB
|
+$212M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$162M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.87% |
| 2 | Healthcare | 13.57% |
| 3 | Financials | 12.24% |
| 4 | Consumer Discretionary | 10.73% |
| 5 | Communication Services | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XLRN
1501
DELISTED
Acceleron Pharma
XLRN
| $22.9M | 0.01% |
240,318
-348,754
| -59% | -$33.6M |
|
1502
HUB Group
HUBG
$2.89B
| $22.9M | 0.01% |
956,330
+14,298
| +2% | +$330K |
|
1503
Fastly Inc
FSLY
$3.69B
| $22.9M | 0.01% |
268,501
+189,588
| +240% | +$7.47M |
|
|
SEM
1504
DELISTED
Select Medical
SEM
| $22.9M | 0.01% |
2,879,727
-1,146,614
| -28% | -$9.5M |
|
1505
MillerKnoll
MLKN
$1.65B
| $22.8M | 0.01% |
966,386
-5,658
| -0.6% | -$128K |
|
1506
Petrobras Class A
PBR.A
$106B
| $22.8M | 0.01% |
2,862,492
+86,677
| +3% | +$608K |
|
|
APLS
1507
DELISTED
Apellis Pharmaceuticals
APLS
| $22.8M | 0.01% |
697,884
+13,015
| +2% | +$418K |
|
|
ITCI
1508
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $22.8M | 0.01% |
886,518
+209,045
| +31% | +$4.23M |
|
|
INOV
1509
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $22.8M | 0.01% |
1,181,383
+47,636
| +4% | +$845K |
|
|
ALTR
1510
DELISTED
Altair Engineering Inc
ALTR
| $22.6M | 0.01% |
568,500
+66,119
| +13% | +$2.25M |
|
1511
Glaukos
GKOS
$10.1B
| $22.6M | 0.01% |
588,021
+67,949
| +13% | +$2.53M |
|
|
FLOW
1512
DELISTED
SPX FLOW, Inc.
FLOW
| $22.6M | 0.01% |
603,349
+14,268
| +2% | +$465K |
|
1513
Editas Medicine
EDIT
$422M
| $22.6M | 0.01% |
763,299
+132,894
| +21% | +$3.47M |
|
1514
SLM Corp
SLM
$5.11B
| $22.5M | 0.01% |
3,202,013
-420,264
| -12% | -$3.14M |
|
1515
Grocery Outlet
GO
$978M
| $22.5M | 0.01% |
551,684
+283,402
| +106% | +$10.1M |
|
1516
Moelis & Co
MC
$5.16B
| $22.5M | 0.01% |
721,811
+101,059
| +16% | +$3.17M |
|
|
DRNA
1517
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $22.5M | 0.01% |
884,606
+165,013
| +23% | +$3.55M |
|
|
ALLK
1518
DELISTED
Allakos
ALLK
| $22.5M | 0.01% |
312,421
+54,203
| +21% | +$3.63M |
|
1519
Palomar
PLMR
$3.54B
| $22.4M | 0.01% |
260,884
+41,753
| +19% | +$2.77M |
|
1520
S&T Bancorp
STBA
$1.84B
| $22.3M | 0.01% |
953,052
-48,065
| -5% | -$1.16M |
|
1521
Ironwood Pharmaceuticals
IRWD
$728M
| $22.3M | 0.01% |
2,162,983
+115,445
| +6% | +$1.18M |
|
1522
Dycom Industries
DY
$12.4B
| $22.3M | 0.01% |
544,968
-5,318
| -1% | -$184K |
|
1523
MACOM Technology Solutions
MTSI
$20.5B
| $22.3M | 0.01% |
648,416
+57,152
| +10% | +$1.67M |
|
1524
Nexstar Media Group
NXST
$5.8B
| $22.3M | 0.01% |
265,962
-5,450
| -2% | -$410K |
|
|
CS
1525
DELISTED
Credit Suisse Group
CS
| $22.3M | 0.01% |
2,158,683
+6,128
| +0.3% | +$55K |
|
Similar funds
Northern Trust's Q2 2020 Portfolio in Review
As of Q2 2020, Northern Trust held 4,386 positions worth $422B, up 21% from $348B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Northern Trust's Q2 2020 filing shows 169 new, 2,281 increased, 1,710 reduced and 126 closed positions. Its largest new stake was Otis Worldwide: 5,015,118 shares worth $285M. The largest sale was Allergan plc, an estimated $720M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Northern Trust's largest Q2 2020 buy was Otis Worldwide: 5,015,118 shares worth $285M.
- Northern Trust added most to AbbVie in Q2 2020, an estimated $335M increase.
- Northern Trust's biggest Q2 2020 reduction was FlexShares Global Upstream Natural Resources Index Fund, cutting an estimated $365M.
- Northern Trust fully exited Allergan plc in Q2 2020, selling an estimated $720M.
- Northern Trust's ten largest holdings make up 21% of its $422B portfolio in Q2 2020.
- Northern Trust opened 169 new positions and closed 126 in Q2 2020.
- Northern Trust's portfolio value rose 21% quarter-over-quarter to $422B.
Based on Northern Trust's 13F filing for Q2 2020, filed 14 Aug 2020.